Spruce Biosciences, Inc. (SPRB) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | 3840.3% |
| Price / Book | 1.68 |
| FCF Yield | -22.0% |
| Altman Z-Score | -4.94 (distress) |
| Sector P/E (Healthcare) | 21.7 |
SPRB overview · SPRB earnings · SPRB KPIs · SPRB investor relations · SPRB ownership · SPRB peers · SPRB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.